UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors?

Clinical and molecular hepatology, 2023-04, Vol.29 (2), p.381-383

2023

Volltextzugriff (PDF)

The Predictive Value of Time-Varying Noninvasive Scores on Long-Term Prognosis of NAFLD in South Korea

Canadian journal of gastroenterology & hepatology, 2024-01, Vol.2024

2024

Volltextzugriff (PDF)

Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean Nationwide Study

Liver cancer (Basel ), 2024-08, Vol.13 (4), p.426-437

2024

Volltextzugriff (PDF)

Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment

Clinical and Molecular Hepatology, 2020, 26(3), , pp.328-339

2020

Volltextzugriff (PDF)

Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study

Clinical and molecular hepatology, 2024-07, Vol.30 (3), p.487-499

2024

Volltextzugriff (PDF)

Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study

Clinical and molecular hepatology, 2024-07, Vol.30 (3), p.500-514

2024

Volltextzugriff (PDF)

Monitoring globotriaosylsphingosine in a Korean male patient with Fabry disease

Kidney Research and Clinical Practice, 2019, 38(2), , pp.250-252

2019

Volltextzugriff (PDF)

Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors?

Clinical and molecular hepatology, 2023, Vol.29 (2), p.381

2023

Volltextzugriff (PDF)

Reply

Hepatology (Baltimore, Md.), 2022-12, Vol.76 (6), p.E140-E140

2022

Volltextzugriff (PDF)

Reply

Hepatology (Baltimore, Md.), 2022-12, Vol.76 (6), p.E140-E140

2022

Volltextzugriff (PDF)

Reply

Hepatology (Baltimore, Md.), 2022-12, Vol.76 (6), p.E140-E140

2022

Volltextzugriff (PDF)

Heart rate is associated with mortality in patients undergoing continuous renal replacement therapy

Kidney Research and Clinical Practice, 2017, 36(3), , pp.250-256

2017

Volltextzugriff (PDF)

Outcomes of Various Classes of Oral Antidiabetic Drugs on Nonalcoholic Fatty Liver Disease

JAMA internal medicine, 2024-04, Vol.184 (4), p.375

2024

Volltextzugriff (PDF)

WED-260 Comparative analysis of Agile 3+, NFS, and BARD scores for diagnosing advanced fibrosis in MASLD and MetALD

Journal of hepatology, 2024-06, Vol.80, p.S532-S532

2024

Volltextzugriff (PDF)

Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study

EClinicalMedicine, 2023-11, Vol.65, p.102292-102292, Article 102292

2023

Volltextzugriff (PDF)

Different class effects of oral hypoglycemic agents on non-alcoholic fatty liver disease regression and clinical outcomes: a nationwide cohort study

Journal of hepatology, 2023-06, Vol.78, p.S814

2023

Volltextzugriff (PDF)

FRI-473 - Different class effects of oral hypoglycemic agents on non-alcoholic fatty liver disease regression and clinical outcomes: a nationwide cohort study

Journal of hepatology, 2023-06, Vol.78, p.S814-S814

2023

Volltextzugriff (PDF)

Reply

Hepatology (Baltimore, Md.), 2022-12, Vol.76 (6), p.E140

2022

Volltextzugriff (PDF)

Reply

Hepatology (Baltimore, Md.), 2022-12, Vol.76 (6), p.E140-E140

2022

Volltextzugriff (PDF)

PNPLA3 genotypes modify the adverse effect of the total energy intake on high-risk nonalcoholic steatohepatitis development

The American journal of clinical nutrition, 2023-05, Vol.117 (5), p.910-917

2023

Volltextzugriff (PDF)

Low‐quality muscle mass rather than normal‐quality muscle mass determines fibrosis progression in biopsy‐proven NAFLD

Alimentary pharmacology & therapeutics, 2023-08, Vol.58 (3), p.322-333

2023

Volltextzugriff (PDF)

Aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B with or without cirrhosis

Hepatology (Baltimore, Md.), 2022-08, Vol.76 (2), p.492-501

2022

Volltextzugriff (PDF)

THU-423 - Long-term prognosis of patients with non-alcoholic fatty liver disease: a retrospective cohort study to understand the impact of surrogate disease end points on long-term outcomes in South Korea

Journal of hepatology, 2023-06, Vol.78, p.S610-S610

2023

Volltextzugriff (PDF)

Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: a nationwide cohort study

Journal of hepatology, 2023-06, Vol.78, p.S1062

2023

Volltextzugriff (PDF)

Long-term prognosis of patients with non-alcoholic fatty liver disease: a retrospective cohort study to understand the impact of surrogate disease end points on long-term outcomes in South Korea

Journal of hepatology, 2023-06, Vol.78, p.S610

2023

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(67)

Publikationsform

Artikel
(77)

Sprache

Englisch
(69)
Koreanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(36)
Life Sciences & Biomedicine
(24)
Physical Sciences
(12)
Chemistry
(11)
Humans
(11)
Gastroenterology & Hepatology
(10)
Technology
(10)
Liver Cancer
(9)
Materials Science
(9)
Materials Science, Multidisciplinary
(8)
Liver Diseases
(7)
Microbiology
(7)
Risk Factors
(7)
Chemistry, Multidisciplinary
(6)
Fatty Liver
(6)
Liver Neoplasms
(6)
Nanostructure
(6)
Chemistry, Physical
(5)
Cohort Studies
(5)
Original
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors?

The Predictive Value of Time-Varying Noninvasive Scores on Long-Term Prognosis of NAFLD in South Korea

Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean Nationwide Study

Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment

Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study

Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study

Monitoring globotriaosylsphingosine in a Korean male patient with Fabry disease

Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors?

Reply

Reply

Reply

Heart rate is associated with mortality in patients undergoing continuous renal replacement therapy

Outcomes of Various Classes of Oral Antidiabetic Drugs on Nonalcoholic Fatty Liver Disease

WED-260 Comparative analysis of Agile 3+, NFS, and BARD scores for diagnosing advanced fibrosis in MASLD and MetALD

Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study

Different class effects of oral hypoglycemic agents on non-alcoholic fatty liver disease regression and clinical outcomes: a nationwide cohort study

FRI-473 - Different class effects of oral hypoglycemic agents on non-alcoholic fatty liver disease regression and clinical outcomes: a nationwide cohort study

Reply

Reply

PNPLA3 genotypes modify the adverse effect of the total energy intake on high-risk nonalcoholic steatohepatitis development

Low‐quality muscle mass rather than normal‐quality muscle mass determines fibrosis progression in biopsy‐proven NAFLD

Aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B with or without cirrhosis

THU-423 - Long-term prognosis of patients with non-alcoholic fatty liver disease: a retrospective cohort study to understand the impact of surrogate disease end points on long-term outcomes in South Korea

Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: a nationwide cohort study

Long-term prognosis of patients with non-alcoholic fatty liver disease: a retrospective cohort study to understand the impact of surrogate disease end points on long-term outcomes in South Korea

Suchergebnisse filtern